JNJ-40411813 Uses, Dosage, Side Effects and more
JNJ-40411813 has been used in trials studying the treatment and basic science of Confusion, Schizophrenia, Perceptual Disorders, and Major Depressive Disorder.
| Attribute | Details |
|---|---|
| Trade Name | JNJ-40411813 |
| Generic | JNJ-40411813 |
| Type | |
| Formula | C20H25ClN2O |
| Weight | Average: 344.88 Monoisotopic: 344.1655411 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
